Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Smith, Gordon
NCT06106672: Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis	Recruiting	1/2	54	US	CNP-106, Placebo	COUR Pharmaceutical Development Company, Inc.	Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis, MuSK MG	06/26	08/26
EPIPHANY, NCT03997981: Chemotherapy Induced Peripheral Neuropathy Natural History Study	Recruiting	N/A	200	US		Disarm Therapeutics, Eli Lilly and Company	Chemotherapy-induced Peripheral Neuropathy	03/24	04/24
NCT04571008: Effect of NMN Supplementation on Organ System Biology	Active, not recruiting	N/A	56	US	Placebo, Treatment	Washington University School of Medicine, United States Department of Defense	Glucose Metabolism Disorders	02/25	09/25
REMOTE-CIPN, NCT04763356: Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy	Recruiting	N/A	422	US	Symptom Care at Home with NP follow up	University of Vermont, Virginia Commonwealth University, University of Utah	Chemotherapy-induced Peripheral Neuropathy	04/26	04/26
Grant, Kami
No trials found